Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6914)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 28, 2020 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fortes FML, Boa Sorte N, Mariano VD, Andrade LD, Oliveira FA, Santos MCA, dos Santos CIN, Passos CA, Pacheco MP, Surlo VC, de Almeida NP, Fontes JAM, Pimentel AM, Rocha R, Santana GO. Active tuberculosis in inflammatory bowel disease patients under treatment from an endemic area in Latin America. World J Gastroenterol 2020; 26(44): 6993-7004 [PMID: 33311945 DOI: 10.3748/wjg.v26.i44.6993] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i44/6993.htm |
| Number | Citing Articles |
| 1 |
Julio Maria Fonseca Chebli, Rogério Serafim Parra, Cristina Flores, Antonio Carlos Moraes, Rodrigo Bremer Nones, Tarcia Nogueira Ferreira Gomes, Ana Maria Bravo Perdomo, Gustavo Scapini, Cyrla Zaltman. Effectiveness and Safety of Ustekinumab for Moderate to Severely Active Crohn’s Disease: Results from an Early Access Program in Brazil. Journal of Clinical Medicine 2022; 11(21): 6481 doi: 10.3390/jcm11216481
|
| 2 |
Matheus Freitas Cardoso de Azevedo, Luísa Leite Barros, Filipe Fernandes Justus, Jane Oba, Karoline Soares Garcia, Camilla de Almeida Martins, Alexandre de Sousa Carlos, André Zonetti Arruda Leite, Aytan Miranda Sipahi, Natália Sousa Freitas Queiroz, Adérson Omar Mourão Cintra Damião. Active tuberculosis in inflammatory bowel disease patients: a case–control study. Therapeutic Advances in Gastroenterology 2023; 16 doi: 10.1177/17562848231179871
|
| 3 |
Domingo Balderramo, Jesús Yamamoto-Furusho, Enrique Ponce de León, Julio de María, Ignacio Zubiaurre, Silvia Pedreira, Camilo Lis, Laura Brion, Juan A. de Paula. Suboptimal response to tumor necrosis factor antagonists in inflammatory bowel disease in Latin America: EXPLORE LATAM study. Gastroenterología y Hepatología 2024; 47(1): 51 doi: 10.1016/j.gastrohep.2023.04.002
|
| 4 |
Domingo Balderramo, Jesús Yamamoto-Furusho, Enrique Ponce de León, Julio de María, Ignacio Zubiaurre, Silvia Pedreira, Camilo Lis, Laura Brion, Juan A. de Paula. Suboptimal response to tumor necrosis factor antagonists in inflammatory bowel disease in Latin America: EXPLORE LATAM study. Gastroenterología y Hepatología (English Edition) 2024; 47(1): 51 doi: 10.1016/j.gastre.2023.04.004
|
| 5 |
Xiaoqing Liu, Lifan Zhang, Fengchun Zhang, Xiaofeng Zeng, Yan Zhao, Qian Wang, Shengyun Liu, Xiaoxia Zuo, Zhiyi Zhang, Huaxiang Wu, Sheng Chen, Hongbin Li, Ping Zhu, Lijun Wu, Wencheng Qi, Yi Liu, Miaojia Zhang, Huaxiang Liu, Dong Xu, Wenjie Zheng, Yueqiu Zhang, Xiaochun Shi, Lishuai Han, Yaou Zhou, Yanping Zhao, Wenwen Wang, Ting Li, Ning Tie, Kui Zhang, Cainan Luo, Baoqi Gong, Yi Zhao, Chengyin Lv, Lijun Song, Qingjun Wu, Yunyun Fei, Lei Zhang, Hui Luo, Jiaying Sun, Jing Xue, Liyang Gu, Jing Wang, Qing Han, Kuerbanjiang Yimaity, Jiaxin Zhou, Lidan Zhao, Sainan Bian, Wufang Qi, Yanhong Li, Yujing Zhu, Huijun Han, Susu Liao, Gaifen Liu. Prevalence and risk factors of active tuberculosis in patients with rheumatic diseases: a multi-center, cross-sectional study in China. Emerging Microbes & Infections 2021; 10(1): 2303 doi: 10.1080/22221751.2021.2004864
|
| 6 |
Flora Maria Lorenzo Fortes, Raquel Rocha, Genoile Oliveira Santana. Thiopurines are an independent risk factor for active tuberculosis in inflammatory bowel disease patients. World Journal of Gastroenterology 2023; 29(9): 1536-1538 doi: 10.3748/wjg.v29.i9.1536
|
| 7 |
Nina Jahnich, Peter D. Arkwright. Regional risk of tuberculosis and viral hepatitis with tumor necrosis factor-alpha inhibitor treatment: A systematic review. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1046306
|
| 8 |
Domingo Balderramo, Abel Botelho Quaresma, Pablo A Olivera, Mariane Christina Savio, Maria Paz Gimenez Villamil, Remo Panaccione, Siew C Ng, Gilaad G Kaplan, Paulo Gustavo Kotze. Challenges in the diagnosis and treatment of inflammatory bowel disease in Latin America. The Lancet Gastroenterology & Hepatology 2024; 9(3): 263 doi: 10.1016/S2468-1253(23)00284-4
|
| 9 |
Vitor Loureiro Dias1, Karin Mueller Storrer1. Prevalence of latent tuberculosis infection among patients with interstitial lung disease requiring immunosuppression. Jornal Brasileiro de Pneumologia 2022; : e20210382 doi: 10.36416/1806-3756/e20210382
|